1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow Hyperlipidaemia: new trials by email Literature Review of Hyperlipidaemia trials Research Report on Hyperlipidaemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| TWICE (Ezetimibe Together With Any Statin Cholesterol Enhancement)(0653-060) MK-0653, ezetimibe, Duration of Treatment: 3 months - Hypercholesterolaemia, Hyperlipidaemia | Phase 3 | Completed | Organon and Co | 1496 | 2004-06-01 | 2024-08-15 |
Hypercholesterolemia (1) · Hyperlipidemias (1)
Dyslipidemias (1) · Lipid Metabolism Disorders (1) · Metabolic Diseases (1) · Nutritional and Metabolic Diseases (1)
Duration of Therapy (1) · Ezetimibe (1)
Organon and Co (1)